{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T17:39:13Z","timestamp":1770140353700,"version":"3.49.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The molecular biomarkers of breast ductal carcinoma in situ (DCIS) have important guiding significance for individualized precision treatment. This study was intended to explore the significance of radiomics based on ultrasound images to predict the expression of molecular biomarkers of mass type of DCIS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>116 patients with mass type of DCIS were included in this retrospective study. The radiomics features were extracted based on ultrasound images. According to the ratio of 7:3, the data sets of molecular biomarkers were split into training set and test set. The radiomics models were developed to predict the expression of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), Ki67, p16, and p53 by using combination of multiple feature selection and classifiers. The predictive performance of the models were evaluated using the area under the curve (AUC) of the receiver operating curve.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The investigators extracted 5234 radiomics features from ultrasound images. 12, 23, 41, 51, 31 and 23 features were important for constructing the models. The radiomics scores were significantly (P\u2009&lt;\u20090.05) in each molecular marker expression of mass type of DCIS. The radiomics models showed predictive performance with AUC greater than 0.7 in the training set and test set: ER (0.94 and 0.84), PR (0.90 and 0.78), HER2 (0.94 and 0.74), Ki67 (0.95 and 0.86), p16 (0.96 and 0.78), and p53 (0.95 and 0.74), respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Ultrasonic-based radiomics analysis provided a noninvasive preoperative method for predicting the expression of molecular markers of mass type of DCIS with good accuracy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12880-021-00610-7","type":"journal-article","created":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T12:03:48Z","timestamp":1621253028000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Preoperative ultrasound radiomics analysis for expression of multiple molecular biomarkers in mass type of breast ductal carcinoma in situ"],"prefix":"10.1186","volume":"21","author":[{"given":"Linyong","family":"Wu","sequence":"first","affiliation":[]},{"given":"Yujia","family":"Zhao","sequence":"additional","affiliation":[]},{"given":"Peng","family":"Lin","sequence":"additional","affiliation":[]},{"given":"Hui","family":"Qin","sequence":"additional","affiliation":[]},{"given":"Yichen","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Da","family":"Wan","sequence":"additional","affiliation":[]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[]},{"given":"Yun","family":"He","sequence":"additional","affiliation":[]},{"given":"Hong","family":"Yang","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,5,17]]},"reference":[{"issue":"5","key":"610_CR1","first-page":"1111","volume":"50","author":"S Wellings","year":"1973","unstructured":"Wellings S, Jensen HJJI. On the origin and progression of ductal carcinoma in the human breast. Origin Breast Carcinoma. 1973;50(5):1111\u20138.","journal-title":"Origin Breast Carcinoma"},{"issue":"18","key":"610_CR2","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1002\/cncr.32200","volume":"125","author":"Y Liu","year":"2019","unstructured":"Liu Y, West R, Weber JD, Colditz GA. Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ. Cancer. 2019;125(18):3225\u201333.","journal-title":"Cancer"},{"issue":"4","key":"610_CR3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10911-018-9416-0","volume":"23","author":"H Villanueva","year":"2018","unstructured":"Villanueva H, Grimm S, Dhamne S, Rajapakshe K, Visbal A, Davis CM, Ehli EA, Hartig SM, Coarfa C, Edwards DP. The emerging roles of steroid hormone receptors in ductal carcinoma in situ (DCIS) of the breast. J Mammary Gland Biol Neoplasia. 2018;23(4):237\u201348.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"2","key":"610_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1200\/JCO.2008.18.3103","volume":"27","author":"HM Kuerer","year":"2009","unstructured":"Kuerer HM, Albarracin CT, Yang WT, Cardiff RD, Brewster AM, Symmans WF, Hylton NM, Middleton LP, Krishnamurthy S, Perkins GH, et al. Ductal carcinoma in situ: state of the science and roadmap to advance the field. J Clin Oncol. 2009;27(2):279\u201388.","journal-title":"J Clin Oncol"},{"key":"610_CR5","first-page":"1","volume":"34","author":"SJ Schnitt","year":"2020","unstructured":"Schnitt SJ. Diagnosis of ductal carcinoma in situ in an era of de-escalation of therapy. Modern. 2020;34:1\u20137.","journal-title":"Modern"},{"key":"610_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ctrv.2017.03.009","volume":"55","author":"C Mart\u00ednez-P\u00e9rez","year":"2017","unstructured":"Mart\u00ednez-P\u00e9rez C, Turnbull AK, Ekatah GE, Arthur LM, Sims AH, Thomas JS, Dixon JM. Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast. Cancer Treat Rev. 2017;55:163\u201372.","journal-title":"Cancer Treat Rev"},{"issue":"8","key":"610_CR7","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1001\/jamaoncol.2016.0525","volume":"2","author":"C Shah","year":"2016","unstructured":"Shah C, Wobb J, Manyam B, Kundu N, Arthur D, Wazer D, Fernandez E, Vicini F. Management of ductal carcinoma in situ of the breast: a review. JAMA Oncol. 2016;2(8):1083\u20138.","journal-title":"JAMA Oncol"},{"issue":"10","key":"610_CR8","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/S1470-2045(19)30420-6","volume":"20","author":"M Giuliano","year":"2019","unstructured":"Giuliano M, Schettini F, Rognoni C, Milani M, Jerusalem G, Bachelot T, De Laurentiis M, Thomas G, De Placido P, Arpino G, et al. Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis. Lancet Oncol. 2019;20(10):1360\u20139.","journal-title":"Lancet Oncol"},{"issue":"3","key":"610_CR9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/his.14140","volume":"77","author":"AI Hida","year":"2020","unstructured":"Hida AI, Omanovic D, Pedersen L, Oshiro Y, Ogura T, Nomura T, Kurebayashi J, Kanomata N, Moriya T. Automated assessment of Ki-67 in breast cancer: the utility of digital image analysis using virtual triple staining and whole slide imaging. Histopathology. 2020;77(3):471\u201380.","journal-title":"Histopathology"},{"issue":"6","key":"610_CR10","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1093\/annonc\/mdz055","volume":"30","author":"V Guarneri","year":"2019","unstructured":"Guarneri V, Dieci MV, Bisagni G, Frassoldati A, Bianchi GV, De Salvo GL, Orvieto E, Urso L, Pascual T, Par\u00e9 L, et al. De-escalated therapy for HR+\/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study. Ann Oncol. 2019;30(6):921\u20136.","journal-title":"Ann Oncol"},{"issue":"8","key":"610_CR11","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/sj.cdd.4400703","volume":"7","author":"M Kim","year":"2000","unstructured":"Kim M, Katayose Y, Rojanala L, Shah S, Sgagias M, Jang L, Jung YJ, Lee SH, Hwang SG, Cowan KH. Induction of apoptosis in p16INK4A mutant cell lines by adenovirus-mediated overexpression of p16INK4A protein. Cell Death Differ. 2000;7(8):706\u201311.","journal-title":"Cell Death Differ"},{"issue":"10","key":"610_CR12","doi-asserted-by":"publisher","first-page":"e76408","DOI":"10.1371\/journal.pone.0076408","volume":"8","author":"M Shan","year":"2013","unstructured":"Shan M, Zhang X, Liu X, Qin Y, Liu T, Liu Y, Wang J, Zhong Z, Zhang Y, Geng J, et al. P16 and p53 play distinct roles in different subtypes of breast cancer. PLoS ONE. 2013;8(10):e76408.","journal-title":"PLoS ONE"},{"issue":"4","key":"610_CR13","first-page":"5084","volume":"16","author":"MW Juan","year":"2018","unstructured":"Juan MW, Yu J, Peng GX, Jun LJ, Feng SP, Fang LP. Correlation between DCE-MRI radiomics features and Ki-67 expression in invasive breast cancer. Oncol Lett. 2018;16(4):5084\u201390.","journal-title":"Oncol Lett"},{"issue":"4","key":"610_CR14","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/bjc.2013.26","volume":"108","author":"L Holmberg","year":"2013","unstructured":"Holmberg L, Wong YN, Tab\u00e1r L, Ringberg A, Karlsson P, Arnesson LG, Sandelin K, Anderson H, Garmo H, Emdin S. Mammography casting-type calcification and risk of local recurrence in DCIS: analyses from a randomised study. Br J Cancer. 2013;108(4):812\u20139.","journal-title":"Br J Cancer"},{"key":"610_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3348\/kjr.2019.0588","volume":"22","author":"SY Won","year":"2020","unstructured":"Won SY, Park HS, Kim EK, Kim SI, Moon HJ, Yoon JH, Park VY, Park S, Kim MJ, Cho YU, et al. Survival rates of breast cancer patients aged 40 to 49 years according to detection modality in Korea: screening ultrasound versus mammography. Korean J Radiol. 2020;22:159\u201367.","journal-title":"Korean J Radiol"},{"issue":"5","key":"610_CR16","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.ultrasmedbio.2017.01.008","volume":"43","author":"T Watanabe","year":"2017","unstructured":"Watanabe T, Yamaguchi T, Tsunoda H, Kaoku S, Tohno E, Yasuda H, Ban K, Hirokaga K, Tanaka K, Umemoto T, et al. Ultrasound image classification of ductal carcinoma in situ (DCIS) of the breast: analysis of 705 DCIS lesions. Ultrasound Med Biol. 2017;43(5):918\u201325.","journal-title":"Ultrasound Med Biol"},{"issue":"1","key":"610_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/jum.15069","volume":"39","author":"W Li","year":"2020","unstructured":"Li W, Zhou Q, Xia S, Wu Y, Fei X, Wang Y, Tao L, Fan J, Zhou W. Application of contrast-enhanced ultrasound in the diagnosis of ductal carcinoma in situ: analysis of 127 cases. J Ultrasound Med. 2020;39(1):39\u201350.","journal-title":"J Ultrasound Med"},{"issue":"1","key":"610_CR18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ultrasmedbio.2018.09.003","volume":"45","author":"HJ Moon","year":"2019","unstructured":"Moon HJ, Kim EK, Kim MJ, Yoon JH, Park VY. Comparison of clinical and pathologic characteristics of ductal carcinoma in situ detected on mammography versus ultrasound only in asymptomatic patients. Ultrasound Med Biol. 2019;45(1):68\u201377.","journal-title":"Ultrasound Med Biol"},{"key":"610_CR19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.breast.2016.10.011","volume":"31","author":"A Evans","year":"2017","unstructured":"Evans A, Vinnicombe S. Overdiagnosis in breast imaging. Breast. 2017;31:270\u20133.","journal-title":"Breast"},{"key":"610_CR20","first-page":"323","volume":"1","author":"A Conti","year":"2020","unstructured":"Conti A, Duggento A, Indovina I, Guerrisi M, Toschi N. Radiomics in breast cancer classification and prediction. Semin Cancer Biol. 2020;1:323\u20134.","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"610_CR21","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278(2):563\u201377.","journal-title":"Radiology"},{"issue":"3","key":"610_CR22","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1148\/radiol.2018172171","volume":"287","author":"K Pinker","year":"2018","unstructured":"Pinker K, Chin J, Melsaether AN, Morris EA, Moy L. Precision medicine and radiogenomics in breast cancer: new approaches toward diagnosis and treatment. Radiology. 2018;287(3):732\u201347.","journal-title":"Radiology"},{"issue":"1","key":"610_CR23","doi-asserted-by":"publisher","first-page":"11921","DOI":"10.1038\/s41598-019-48488-4","volume":"9","author":"WQ Luo","year":"2019","unstructured":"Luo WQ, Huang QX, Huang XW, Hu HT, Zeng FQ, Wang W. Predicting breast cancer in breast imaging reporting and data system (BI-RADS) ultrasound category 4 or 5 lesions: a nomogram combining radiomics and BI-RADS. Sci Rep. 2019;9(1):11921.","journal-title":"Sci Rep"},{"key":"610_CR24","doi-asserted-by":"publisher","first-page":"573630","DOI":"10.3389\/fonc.2020.573630","volume":"10","author":"F Lin","year":"2020","unstructured":"Lin F, Wang Z, Zhang K, Yang P, Ma H, Shi Y, Liu M, Wang Q, Cui J, Mao N, et al. Contrast-enhanced spectral mammography-based radiomics nomogram for identifying benign and malignant breast lesions of sub-1 cm. Front Oncol. 2020;10:573630.","journal-title":"Front Oncol"},{"issue":"2","key":"610_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/annonc\/mdx651","volume":"29","author":"F Cardoso","year":"2018","unstructured":"Cardoso F, Bartlett JMS, Slaets L, van Deurzen CHM, van Leeuwen-Stok E, Porter P, Linderholm B, Hedenfalk I, Schr\u00f6der C, Martens J, et al. Characterization of male breast cancer: results of the EORTC 10085\/TBCRC\/BIG\/NABCG International Male Breast Cancer Program. Ann Oncol. 2018;29(2):405\u201317.","journal-title":"Ann Oncol"},{"issue":"6","key":"610_CR26","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1007\/s00330-018-5797-0","volume":"29","author":"HT Hu","year":"2019","unstructured":"Hu HT, Wang Z, Huang XW, Chen SL, Zheng X, Ruan SM, Xie XY, Lu MD, Yu J, Tian J, et al. Ultrasound-based radiomics score: a potential biomarker for the prediction of microvascular invasion in hepatocellular carcinoma. Eur Radiol. 2019;29(6):2890\u2013901.","journal-title":"Eur Radiol"},{"issue":"21","key":"610_CR27","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJM van Griethuysen","year":"2017","unstructured":"van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, Beets-Tan RGH, Fillion-Robin JC, Pieper S, Aerts H. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 2017;77(21):e104\u20137.","journal-title":"Cancer Res"},{"key":"610_CR28","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.3389\/fonc.2020.01646","volume":"10","author":"Y Peng","year":"2020","unstructured":"Peng Y, Lin P, Wu L, Wan D, Zhao Y, Liang L, Ma X, Qin H, Liu Y, Li X, et al. Ultrasound-based radiomics analysis for preoperatively predicting different histopathological subtypes of primary liver cancer. Front Oncol. 2020;10:1646.","journal-title":"Front Oncol"},{"issue":"4","key":"610_CR29","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s00259-018-4231-9","volume":"46","author":"F Lucia","year":"2019","unstructured":"Lucia F, Visvikis D, Valli\u00e8res M, Desseroit MC, Miranda O, Robin P, Bonaffini PA, Alfieri J, Masson I, Mervoyer A, et al. External validation of a combined PET and MRI radiomics model for prediction of recurrence in cervical cancer patients treated with chemoradiotherapy. Eur J Nucl Med Mol Imaging. 2019;46(4):864\u201377.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"610_CR30","doi-asserted-by":"publisher","first-page":"e1003149","DOI":"10.1371\/journal.pmed.1003149","volume":"17","author":"N Atabaki-Pasdar","year":"2020","unstructured":"Atabaki-Pasdar N, Ohlsson M, Vi\u00f1uela A, Frau F, Pomares-Millan H, Haid M, Jones AG, Thomas EL, Koivula RW, Kurbasic A, et al. Predicting and elucidating the etiology of fatty liver disease: a machine learning modeling and validation study in the IMI DIRECT cohorts. PLoS Med. 2020;17(6):e1003149.","journal-title":"PLoS Med"},{"issue":"3","key":"610_CR31","doi-asserted-by":"publisher","first-page":"434","DOI":"10.4081\/gh.2016.434","volume":"11","author":"T Kapwata","year":"2016","unstructured":"Kapwata T, Gebreslasie MT. Random forest variable selection in spatial malaria transmission modelling in Mpumalanga Province, South Africa. Geospat Health. 2016;11(3):434.","journal-title":"Geospat Health"},{"issue":"14","key":"610_CR32","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1158\/1078-0432.CCR-19-4207","volume":"26","author":"XP Tian","year":"2020","unstructured":"Tian XP, Su N, Wang L, Huang WJ, Liu YH, Zhang X, Huang HQ, Lin TY, Ma SY, Rao HL, et al. A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic Lymphoma. Clin Cancer Res. 2020;26(14):3760\u201370.","journal-title":"Clin Cancer Res"},{"key":"610_CR33","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/bib\/bbaa170","volume":"22","author":"SM Naeem","year":"2020","unstructured":"Naeem SM, Mabrouk MS, Marzouk SY, Eldosoky MA. A diagnostic genomic signal processing (GSP)-based system for automatic feature analysis and detection of COVID-19. Brief Bioinform. 2020;22:1197\u2013206.","journal-title":"Brief Bioinform"},{"key":"610_CR34","first-page":"1","volume":"54","author":"N Dey","year":"2020","unstructured":"Dey N, Rajinikanth V, Fong SJ, Kaiser MS, Mahmud M. Social group optimization-assisted Kapur\u2019s entropy and morphological segmentation for automated detection of COVID-19 infection from computed tomography images. Cognit Comput. 2020;54:1\u201313.","journal-title":"Cognit Comput"},{"issue":"2","key":"610_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00000658-198008000-00001","volume":"192","author":"D Rosner","year":"1980","unstructured":"Rosner D, Bedwani RN, Vana J, Baker HW, Murphy GP. Noninvasive breast carcinoma: results of a national survey by the American College of Surgeons. Ann Surg. 1980;192(2):139\u201347.","journal-title":"Ann Surg"},{"key":"610_CR36","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.breast.2016.09.001","volume":"31","author":"EJ Groen","year":"2017","unstructured":"Groen EJ, Elshof LE, Visser LL, Rutgers EJT, Winter-Warnars HAO, Lips EH, Wesseling J. Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS). Breast. 2017;31:274\u201383.","journal-title":"Breast"},{"issue":"6","key":"610_CR37","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/j.1365-2354.2011.01265.x","volume":"20","author":"C Davey","year":"2011","unstructured":"Davey C, White V, Warne C, Kitchen P, Villanueva E, Erbas B. Understanding a ductal carcinoma in situ diagnosis: patient views and surgeon descriptions. Eur J Cancer Care. 2011;20(6):776\u201384.","journal-title":"Eur J Cancer Care"},{"key":"610_CR38","doi-asserted-by":"publisher","first-page":"5543","DOI":"10.1158\/1078-0432.CCR-20-2451","volume":"26","author":"NB Hunter","year":"2020","unstructured":"Hunter NB, Kilgore MR, Davidson NE. The long and winding road for breast cancer biomarkers to reach clinical utility. Clin Cancer Res. 2020;26:5543\u20135.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"610_CR39","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","volume":"121","author":"M van Seijen","year":"2019","unstructured":"van Seijen M, Lips EH, Thompson AM, Nik-Zainal S, Futreal A, Hwang ES, Verschuur E, Lane J, Jonkers J, Rea DW, et al. Ductal carcinoma in situ: to treat or not to treat, that is the question. Br J Cancer. 2019;121(4):285\u201392.","journal-title":"Br J Cancer"},{"issue":"11","key":"610_CR40","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1097\/PAS.0000000000001306","volume":"43","author":"LL Visser","year":"2019","unstructured":"Visser LL, Elshof LE, Van de Vijver K, Groen EJ, Almekinders MM, Sanders J, Bierman C, Peters D, Hofland I, Broeks A, et al. Discordant marker expression between invasive breast carcinoma and corresponding synchronous and preceding DCIS. Am J Surg Pathol. 2019;43(11):1574\u201382.","journal-title":"Am J Surg Pathol"},{"issue":"12 Pt 1","key":"610_CR41","first-page":"2329","volume":"3","author":"GJ Zhang","year":"1997","unstructured":"Zhang GJ, Kimijima I, Abe R, Kanno M, Katagata N, Hara K, Watanabe T, Tsuchiya A. Correlation between the expression of apoptosis-related bcl-2 and p53 oncoproteins and the carcinogenesis and progression of breast carcinomas. Clin Cancer Res. 1997;3(12 Pt 1):2329\u201335.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"610_CR42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/PAI.0000000000000223","volume":"24","author":"JE Davis","year":"2016","unstructured":"Davis JE, Nemesure B, Mehmood S, Nayi V, Burke S, Brzostek SR, Singh M. Her2 and Ki67 biomarkers predict recurrence of ductal carinoma in situ. Appl Immunohistochem Mol Morphol. 2016;24(1):20\u20135.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"11","key":"610_CR43","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1002\/cncr.20260","volume":"100","author":"DB Cornfield","year":"2004","unstructured":"Cornfield DB, Palazzo JP, Schwartz GF, Goonewardene SA, Kovatich AJ, Chervoneva I, Hyslop T, Schwarting R. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone. Cancer. 2004;100(11):2317\u201327.","journal-title":"Cancer"},{"issue":"1","key":"610_CR44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jacr.2009.09.022","volume":"7","author":"CH Lee","year":"2010","unstructured":"Lee CH, Dershaw DD, Kopans D, Evans P, Monsees B, Monticciolo D, Brenner RJ, Bassett L, Berg W, Feig S, et al. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol. 2010;7(1):18\u201327.","journal-title":"J Am Coll Radiol"},{"issue":"4","key":"610_CR45","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1007\/s00330-018-5668-8","volume":"29","author":"A Vourtsis","year":"2019","unstructured":"Vourtsis A, Berg WA. Breast density implications and supplemental screening. Eur Radiol. 2019;29(4):1762\u201377.","journal-title":"Eur Radiol"},{"issue":"4","key":"610_CR46","first-page":"Cd009632","volume":"2013","author":"G Gartlehner","year":"2013","unstructured":"Gartlehner G, Thaler K, Chapman A, Kaminski-Hartenthaler A, Berzaczy D, Van Noord MG, Helbich TH. Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk. Cochrane Database Syst Rev. 2013;2013(4):Cd009632.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"610_CR47","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.clbc.2020.02.009","volume":"20","author":"H Pu","year":"2020","unstructured":"Pu H, Peng J, Xu F, Liu N, Wang F, Huang X, Jia Y. Ultrasound and clinical characteristics of false-negative results in mammography screening of dense breasts. Clin Breast Cancer. 2020;20(4):317\u201325.","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"610_CR48","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.crad.2019.10.009","volume":"75","author":"DS Gunawardena","year":"2020","unstructured":"Gunawardena DS, Burrows S, Taylor DB. Non-mass versus mass-like ultrasound patterns in ductal carcinoma in situ: is there an association with high-risk histology? Clin Radiol. 2020;75(2):140\u20137.","journal-title":"Clin Radiol"},{"issue":"2","key":"610_CR49","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/jmri.25479","volume":"45","author":"SC Partridge","year":"2017","unstructured":"Partridge SC, Nissan N, Rahbar H, Kitsch AE, Sigmund EE. Diffusion-weighted breast MRI: clinical applications and emerging techniques. J Magn Reson Imaging. 2017;45(2):337\u201355.","journal-title":"J Magn Reson Imaging"},{"key":"610_CR50","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1093\/jnci\/djaa018","volume":"112","author":"PO Alderson","year":"2020","unstructured":"Alderson PO, Summers RM. The evolving status of radiomics. J Natl Cancer Inst. 2020;112:869\u201370.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"610_CR51","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.zemedi.2018.11.002","volume":"29","author":"AS Lundervold","year":"2019","unstructured":"Lundervold AS, Lundervold A. An overview of deep learning in medical imaging focusing on MRI. Z Med Phys. 2019;29(2):102\u201327.","journal-title":"Z Med Phys"},{"issue":"6","key":"610_CR52","doi-asserted-by":"publisher","first-page":"e0234871","DOI":"10.1371\/journal.pone.0234871","volume":"15","author":"A Demircioglu","year":"2020","unstructured":"Demircioglu A, Grueneisen J, Ingenwerth M, Hoffmann O, Pinker-Domenig K, Morris E, Haubold J, Forsting M, Nensa F, Umutlu L. A rapid volume of interest-based approach of radiomics analysis of breast MRI for tumor decoding and phenotyping of breast cancer. PLoS ONE. 2020;15(6):e0234871.","journal-title":"PLoS ONE"},{"key":"610_CR53","first-page":"568","volume":"23","author":"J Zhou","year":"2020","unstructured":"Zhou J, Tan H, Li W, Liu Z, Wu Y, Bai Y, Fu F, Jia X, Feng A, Liu H, et al. Radiomics signatures based on multiparametric MRI for the preoperative prediction of the her2 status of patients with breast cancer. Acad Radiol. 2020;23:568\u201398.","journal-title":"Acad Radiol"},{"key":"610_CR54","doi-asserted-by":"publisher","first-page":"37241","DOI":"10.1038\/srep37241","volume":"6","author":"P Prasanna","year":"2016","unstructured":"Prasanna P, Tiwari P, Madabhushi A. Co-occurrence of local anisotropic gradient orientations (CoLlAGe): a new radiomics descriptor. Sci Rep. 2016;6:37241.","journal-title":"Sci Rep"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-021-00610-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-021-00610-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-021-00610-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T12:08:03Z","timestamp":1621253283000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-021-00610-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,17]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["610"],"URL":"https:\/\/doi.org\/10.1186\/s12880-021-00610-7","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,17]]},"assertion":[{"value":"4 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective breast DCIS study was approved by the ethics committee of the First Affiliated Hospital of Guangxi Medical University. Informed consent was waived. This study on the implementation of all procedures are in line with the National Research Council of moral standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}